Skip to main content
. 2012 Sep 25;8(2):199–207. doi: 10.1007/s12263-012-0321-7

Table 1.

Characteristics of the sample

Cases (n = 218) Controls (n = 236) p
Age, year: mean ± SD (median) 67.8 ± 7.8 (69.0) 61.7 ± 10.7 (64.0) 0.0001
Weight, kg: mean ± SD 72.4 ± 13.8 73.4 ± 14.5 0.358
Height, cm: mean ± SD 169.6 ± 6.6 171.4 ± 7.0 0.007
BMI, kg/m2: mean ± SD 25.1 ± 4.6 24.9 ± 4.1 0.751
Education (%)
 Primary or less 90.1 80.8 0.011
 Secondary or higher 9.9 19.2
Smoking (%)
 Non-smoker 23.0 24.5 0.900
 Ex-smoker 61.5 59.4
 Current smoker 15.5 16.2
Alcohol intake
 Non-drinker 67.9 59.7 0.176
 <6.4 g/day 15.8 19.5
 >6.4 g/day 16.3 20.8
Family history of prostate cancer (%) 16.1 11.0 0.116
Vitamin use 22.8 30.0 0.102
Cases only (% n)
 Low-grade cancera 43.5 (95)
 High-grade cancerb 53.2 (116)
 Unknown 3.2 (7)
Serum folate. nmol/L: mean ± SD (median) 12.3 ± 4.1 (12.4) 9.7 ± 4.2 (9.1) 0.0001
Folate intake (μg/d): mean ± SD (median) 754 ± 274 (757) 793 ± 294 (768) 0.158

aLow-grade cancer indicates Gleason score of <7

bHigh-grade cancer indicates Gleason score of ≥7